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Bcukpend. PB(ieuts wi!h Ihe idiopa!hic Ion8 QT sycdreae 
are at h&h risk for sudden cardiac death. Before combination 
therapy, 10 af the 21 study patients exprienred either cardiac 
arres, (n = 8, or syncop In = L8, and It had documented 
polymorphous ventricular lachycardia. Nine of these pfdients had 
not responded to imlated beta.hlocker therapy sod five had not 
responded to Mated left cervtcothoractc sympathrctomy. 
Melhod. All patients were treated with cambbwd betablocker 
therapy and long-term cardiac pacing at a rate designed to 
normalize the QT interval. 
RemUs. Cardiac pacing at rates 0170 to 125 bealsimio resulted 
in shortening of the QT and corrected QT tQTc) intervals from 
9, * 7h and 541 * 67. Ins to 404 * 37 and 479 * 4, Ins. 
respectively. The mean foltow-up intwvst alter institution of 
pacing was 55 I 45 months. The only sudden death occurred in B 
patient who had discontinued bet&blocker therapy. Syncope 
wrurred in four patients, two of whom had inten’upted pace- 
maker function dw to lead Srarture. Pacemaker pmbiena, panty 
attributable to the scecitie rate reouired for OT interval shorten- 
ing and to avoidance OFT wave &tug, were relatively crmuuou. 
No ostient who continued the combination theraw died. hut 10% 
of these patients had a rwurreoce al symptoms:~ 
Conclusions. Combination therapy with a beta-btwker and 
eardine pacing appws to be P highly et&live primary therapy 
for symptomatic patients with the long QT syndrome and tu 
rrovtde excellent adiunctive thsrarv fur oatieuts who wudre 
&tian ol an auto~atii ioternal &lhrilk&r. 
(I Am Call Cardiol1991;20;830-7) 
The relation between sudden cardiac death and cardiac 
arrhythmias in patients with the long QT syndrome was first 
described by Fraser et al. (1). In that study and in subse- 
quent reports, the relation between bradycardia and the long 
QT syndrome was reponed (2). Bradycardia may bc r&ted 
to abnormal sympathetic activation of the heart (3). lo 1987, 
!ve (2) desxibed !be rcmbined ace of bets adreoersc block. 
ing agents and long-term cardiac pacing in the treatment of 
patients with the long QT syndrome with or without brady- 
cardia. In thal sludy. we repurted on eight patients who 
responded to such combinatmn therapy over a relatively 
short follow-up interval after traditional therapy had proved 
unsuccessful. The combination therapy was designed to 
prevenl holh pauses and increered adrenergic tone. either of 
which might trigger episodes of polymorphous ventricular 
tachycardia. Since the initial report, we have used combina- 
tion therapy for PSI symptomatic patients with the long QT 
syndrome referred tu our medical cemer. In this repon we 
update ourcumnt experience, emphasizing rhe benefits and 
potential problems with this approach. 
Methods 
This report includes follow-up information on the 8 pa- 
tient: with the !sng QT syndrome previously reported on and 
an additional 13 patients who have received combination 
therapy since the original report. The clinical data for these 
patients are detailed in Table 1. All but one patient was 
symptomatic and had consistent prolongation of the QT 
interval to >440 ms and a corrected QT (QTc) interval 
>450 ms unrelated to any identifiable cause. Baseline eval- 
uation iwbded -11 echocardiogram in all patients and exer- 
cise treadmill testing in all but Patient 19. No patient had 
evidence of cardiac disease, and the QT interval shortened in 
all patients in response to treadmill exercise (2). The results 
of tilt table testing, performed in four patients (Patients la, 
13. 14 and IS). were normal. 
Patients were treated with maximal tolerated doses of one 
or more beta-blockers and insertion of a cardiac pacemaker. 
The pacemaker rate was adjusted to the mimmal rate re- 
quueo to nonnahze the QT mtcrval. The exact pacio8 mode 
and beta-blocker dose used are detailed in Table 2. Family 
members with a prolonged QT inlerval but without symp- 
tams were treated with beta-blockers; those with a normal 
QT interval were not Irecued. 
The baseline QT and QTc intervals were prolonged in all 
except Patient 13. who was resuscitated from cardiac arrest 
and who is the daughter of Patient 4. Atrial demand pacing 
(AAD was initiated in eight patients; in one of these (Patient 
3). the pacemaker was upgraded to a dual-chamber system 
(DDD). Since July 1989. all patients have received either a
ventricular demand (VVI) or a dun!-chamber (DDD) pece- 
maker. In one (Patient IS), the pacemaker was later pro- 
grammed to AAI mode. 
Ethics uf the study. Combined beta-blocker therapy and 
chronic pacing has become one of the standard modes of 
therapy for patients with the long QT syndrome. Our study 
was a descriptive prospective study of patients under our 
care. The study design in no way interfered with standard 
tale. 
Patlent follow-up. The patients were followed up at least 
every 6 months either at our arrhythmia clinic or by the 
referring physician. If symptoms recurred, intensive efforts 
were made to discern their cause. In addition, all patients 
underwent regular pacemaker evaluation and 24-h ambula- 
tory 4ectmcardiogmphic (ECG) monitoring as clinically 
indicated. Twelve-leaa EtXis were obtained at these limes 
to documeut persistent normalization uf the QT interval. All 
but three patients were folIowed up at the University of 
California, San Francisco Medical Center. Follow-up data 
from two patients included in our original report were 
obtained from the referring physicians at their respective 
institutions (the University of Minnesota and the University 
of Southern California). One patient currently resides in 
Hawaii and is followed up there. All except Patient 21 were 
followed up for a minimum of 6 months. 
RBllltS 
Clinical features. The stcdy g:ao> consisted of 21 pa- 
tients, Ii women and 4 men. aged 2 to 63 years (mean 28 t
is). Ten patients were from six families with the Romano- 
Ward syndrome and one patient had the Jervell-Lange- 
Nielsen syndrome. Eight patients had a history of one to four 
episodes of resuscitation from sudden cardiac arrest. One 
asymptomatic relative with QT interval prolongation re- 
ceived combined therapy because of spantaneous atrioven- 
tricular (AV) block and ventricular ectopic activity in ass~- 
ciation with a family history of sudden cardiac death. 
Eighteen patients had a history of one or more syncopal 
episodes and II had documented polymorphous ventricular 
tachycardia. Five of the 21 patients had episodes of AV 
block but none had bradyarrhythmias. 
Uwtccessful pnor therapy IS aetaiied m Table 2. Nine 
patients did not respond to trials of selective and nonselec- 
tive be%-adrenergic blocking agents. Iabetalot, which has 
bath beta- and alpha-adrenergic blocking &es. was not 
used because there is little experience with its use in patients 
with the long QT syndrome. Five of the nine also had 
unsuccessful left cervicothoracic sympathectomy. 
The baseline range of the QT and QTc intervals was 440 
to 640 ms (mean 517 i 78) and 450 to 670 tns (mean 541 + 
62), respectively. After long-term pacing at 70 to 125 beats/ 
min (wan 83 + IZ), the mean QT and QTc intervals 
decreased to 404 r 37 and 479 + 41 ms. respectively. 
Follow-up. All patients but one were followed up for a 
minimum of 6 months (Table 2). The mean duration of 
follow-up for the group as a whole was 55 f 45 months 
(range 1 to 1%). Among patients who maintained both 
long-term beta-blocker therapy and consistent long-term 
pacing, only two had a cardiac event. In Patient 2. who was 
treated with an AA1 pacemaker and had an unexplained 
syncopal episode during a casual telephone conversation, a 
dual-chamber pacemalter was inserted to enslude intermit- 
tent AV block. Because further evaluation with continuous 
ECG monitoring, tilt table testing, exercise treadmill testing 
and invasive electraphysiologic studies failed to pinpoint the 
cause of syncope. an interval defibrillator was inserted. This 
patient is correo!!y wi!hout symptoms and has not had a 
defibrillator discharge during a &month follow-up interval. 
Patient IO had recurrent episodes of potpmorphoos ventric- 
ular tachycardia and ventricular fibrillation (Fig. 1, A to 0, 
and was initially treated with left cervicotboracic sympa- 
thectomy at another hospital. She remained free of arrhyth- 
mias for 48 h after operation but had an episode of polymer- 
phous ventricular tachycardia similar to those that occurred 
preoperatively (Fig. ID). Revision of her pacemaker to a 
dual-chamber unit resulted in prompt disappearance of the 
arrhythmias (Fig. IE). She I& had nos)%~ptoms on a 
regimen of beta-blockers, phenytoin and long-term dual- 
chamber pacing over a follow-up interval of appmximately 6 
months. 
The remaining events occurred in three patients with 
lapses in combination therapy. Patient 20. with a history of 
multiple syncopal episodes, was successfully treated with 
combination therapy for 5 years. She subsequently joined a 
religious group that convinced her to discontinue drug 
therapy and she died suddenly 3 months later. Patients 3 and 
19 had recurrences of :he original symptoms related to 
pacemaker lead fracture. One of the leads was epicardial, 
Implanted in a I-month old baby; the other was an cndocar- 
dial lead implanted in a i&year old girl. The cause of 
symptoms was not documented in these patients but nymp 
toms disappeared in both patients when effective pacing was 
reeaablisbed. 
Figure 1. Patient 10. Electrocardiographic rhythm strips. A, Strip 
showing ventricular pacing in a ventricular demand (VU) mode 
with ventricular bigeminy. The QT interval is prolonged for the 
oacedcometexer lSDOmsl andthe OTU interval is oroloneed for one 
spontaneously conducted complex-&eat 6,. The p;em&& ventric- 
ular complexes are not sensed by the pacemaker. 8. Episode of 
rpantancous nonsustained polymorphous ventricular tachycardia 
that beginswitha sequenceofapaced beatfollwpd by aventricular 
premture beat practically identical to that in panel A. C, Episode of 
~pantaneous palymolphous ventricular tachycardia that deterio- 
rated into ventricular fibrillation and required direct wment shock. 
0, Forty-eight hours after ympathectomy: an episode of spontane- 
ou: polymorphous ventricular tachycardm. beginning with a se- 
quence very sin&t to Iha1 in panels A and 8. The bt premature 
complex is distorted by a pacemaker spike (arrow). The tachycardia 
deteriorated into ventricular Fbrillation and required electrical 
shock. E. After sytnpathcctomy and dual-chamber pacing. the QT 
interval is normal (3M) ms). 
periods of the& patients the requirement to avoid 
pauses resulted in unique pacemaker problems. We aban- 
doned AA1 pacing for the reasons illustrated by Cases 12 and 
19. In Patient 19 spontaneous 2:l AV block developed after 
a premature ventricular depolarization (4). The compensa- 
tory pause tier the premature ventricular depolarization 
resulted in prolongation of refractoriness, presumably at the 
level of the His bundle, and initiated episodes of 2: I AV 
block. This type of response would not be avoided by using 
AA1 pacing. Patient I2 had spontaneous episodes of AV 
Wencksbach block (particularly during sleep) that may have 
been in pan related to the concomitant beta-blocker therapy. 
Even the use of VVI or dual-chamber pacing has not 
obviated 211 problems. The relatively rapid pacing rates and 
the long ventricular effective refractory period require care- 
fu! attennon to programming variables, parttcularly with 
dual-chamber pacemakers as shown in the following cases. 
Pacemaker syndrome developed in Patient 9 after i&ion 
of a DDD pacemaker. This case was previously reported (5) 
and will be briefly summarized. When the pacemaker w:‘as 
oroerammed to a lower rate of85 beatslmin and an AV de!ay 
of 250 ms (to shorten the QT interval and minimize venttic- 
ular pacing). episodic dyspnea and neck pulsations devel- 
oped. Endocardial tetemetry during a symptomatic episode 
showed retrograde ventriculaatrial conduction presumably 
initiated by a premature ventricular depolarization. The 
retrograde P wave resulted in atrial contraction against 
closed AV valves but was not sensed because it occurred 
within ihe pacemaker postventricular atria1 refractory pe- 
nod. The next atrial stimulus f&d to capture because of 
atrial refractoriness, and ventricular pacing occurred after an 
appropriately programmed AV delay and the cycle perpan- 
ated itself. To maintain a heart rate necessary to normalize 
the QT interval, the AV delay was repmg&med from 250 
to 200 ms. which allowed for atrial caoiure bv the atrial 
stimulus. 
Another unioue oacine oroblem was encountered in Pa- . . I. 
tient 16. who underwem pacing at a rate of SO beatslmin in 
the AV mode. The routine 24-h ambulators ECG recordins 
showed episodic prolonged pauses that were terminated by 
conducted sinus complexes (Fig. 2A). T wave oversensing 
was suspected but endowdial telemetry from the tight 
ventticuiar lead revealed episodic potentials that occurred 
after comnletlon of the T waves (Fii. 2B). These potentials 
were sensed by the ventricular iead and delayed the next 
atrial stimulus. which resolted in the muses. This moblem 
could be solved either by AV pa& at a rate- of IM) 
beats/rein (which resulted in loss of these potentials (Fig. 2C) 
or by pacing in the AAI mode at a rate of NJ bealslmin. This 
patient showed no evidence of a lead problem as reflected by 
multiole random cotemials or bv f&Hz noise. and imced- 
ante bfthe ve&ular lead was &utal. The potentials&e 
thought to be possibly related to early afterdepolarizations 
that at slower rates achieved an amplitude sensed by the 
ventricular lead. The pacemaker was programmed !o the 
AA1 mode and the patient has had no symptoms during a 
followup period of 2 months. 
Patient I9 undet?went pacing in the WI mode at a set rate 
of I20 heatsiinin with a long programmed ventricular refrac- 
tory period of 32.3 ms designed to avoid T wave sensing. The 
patient developed seizures, and the monitoring strip showed 
sinus tachycardir at a rate of 214 beatsImin with conducted 
beats that fell inside the pacemaker ventricular refractory 
period, allowing for the subsequent ventricular stimulus to 
fall on the T wave and trig&% short episodes of nonsustained 
ventricular tachycardia (Fig. 3A). The problem was cor- 
Figure 3. Patient 19. A. Electrocardiographic WC) rhythm strip 
showing sinus mchycardia (rate 214 beats/&l wirh phaaic aber- 
rancy aad undersensing resulting in aventricular spike Mingon the 
T wave and sometimes producing short bursts of nonsuslained 
monomorphic venlricular tachycardia. B, ECG strip showing sinus 
rhythm with normal sensing after the ventricular e&&e refractory 
periad was shortened to 280 ms. 
Patient 13, Ihe daughter of Patient 4, is of particular 
interest. All family members were screened, and two of her 
brothers were found to have QT prolongation and were 
I ) , ’ / 
ecg...+.A-” ,--‘,.C’..“‘._~~yrr.~-, ,& 
Figure 2. Patient 16. A. Electrocardiographic (ECG) rhythm strip 
showing atrial pacing and renlricular capture. A pause follows the 
faurth complex and IS tcrmmated by an escape sinus complex. The 
escape complex is characterized by atrial and ventricular events not 
sensed by the pacemaker. The observed ventriculoarterial intervals 
su~e~ls the, the pause war due 10 a sensed “entncular event 
occurring tier the preceding T wave. 8, Simultaneous recording of 
telemetered bipolar ventricular intracardiac electmgram lie) and 
surface ECG lead showmg that the pause is preceded by a large 
intracardiac porendal occurdng after inscriprion of rhe T wave. 
Wracardiac elecsograa gain 10 m”,division. paper speed 
1S mm/s.) C, Recordings as in 8. The atria1 paced rate was increased 
to IW bcatsimin. which rcsultcd in Ihc disappearance of Ihe intrzv 
cudiac potenti d and pauses in both bipolar and unipolar recording 
modes. (Gsm 20 mV/division, paper speed 25 mmis.: 
rected by shortening the refractory period to 280 ms (Fig. 
38). 
Value of dual therapy. The importance of dual therapy 
with beta-blockers and cardiac pacing is well illustrated by 
the three patients who had recurrent symptoms with either 
cessation of drug treatment or pacemaker m&n&n, and 
particularly by Patient 19 (4). This patienl presented in utero 
with irregular heart rate, and incessant episodes of polymor- 
phous venlriculartachycardia were noted on day 1 (Fig. 4A). 
She was treated with oral propranolol without beneficial 
effect and required frequent cardwersionr. Polymorphous 
ventricular tachycardia was related to episodes of functional 
2:1 AV block. Ventricular overdrive pacing 3t a rate of 150 
beatslmio inmediaiely eliminated 811 episodes of polymo;. 
phous venlricular tachycardia (Fig. 48). 
Figure4. Patient 19. A. Top and middle panel ofduakhannel Halter 
ambulatory electrocardiographic recording showing an episode of 
ventricularbigeminy preceding an episode ofpolymorphous vent+ 
ular lachycardia that spantaneausly terminates. Episodes of poly- 
morphous ventricular tachycardia occurred despite beta-blocker 
therapy. Reproduced, by permission. from Van Hare et al. (4). 8, 
After ventricular pacing in the VW mode at IS0 beatrlmin, showing 
normalization of the QT interval and disappearance of the polymor- 
phous ventricular tachycardia. 
A 
treated with heta-blockers. Because Patient 13 was asymp- 
tom& with normal serial ECG findings. it was decided not 
to treat her. While at school. she had a cardiac arrest due to 
documented ventricular fibrillation and was successfully 
resuscitated. Results of her echocardiogram. tilt table !est, 
exercise treadmill test and invasive electrophysiologic study 
were normal. She was treated wth a dual-chamber pace- 
maker and a beta-blocker and has remained asymptomatic 
during a follow-up interval of 22 months. 
Discussion 
as an alternative therapeutic approach (6). A recent report 
from the worldwide registry documented the efficacy of 
sympathectomy in drug-resistant patients but also showed a 
45% incidence rate of recurrent cardiac events over an 
approximately 6-year follow-up period (IO). These events. 
which included sudden death (80% incidence rate) and 
Prior experience. Patients with the rdropathic long QT 
syndrome are at high risk for sudden cardiac death. Recog- 
nized high risk factors include a family history of sudden 
death and a history of syncope (6). Although beta-blocker 
therapy has been shown to be effective. it has limitations 
when used alone, as recently described in data collected 
from an international registry (6-9). Of 250 patients wilh the 
long QT syndrome treated with beta-blockers alone. 6% died 
suddenly and approximately 20% had recurrent syncope 
(6-9). Left cervicothoracic sympathcctomy involving resec- 
tion of the lower portmn of the left stellate ganglion together 
with the first five to six thoracic ganglia has been suggested 
powbdny of a pause-triggered event. The other (Patient IO) 
bad documented polymorphous ventticular tacbycardia de- 
adrenelgic tone might trigger polymorphous ventricular 
spire a properly functioning VVI pacemaker and maximally 
tolerated beta-blocker therapy. This pa&t showed a per- 
tachycxdia. Other investigators (E-15). for example. have 
sistent bigeminal rhythm that preceded the tachycardia 
episodes. A prolonged episode of polymorphous ventricular 
sugges’ed the possible role of alpha-receptor stimulation in 
tachycardia that deteriorated into ventricular fibrillation was 
documented after symparhecmmy. For reasons that are nor 
provoking arrhythmias in these patients. 
clear. ?he patient’scondition finally stabilized after the use of 
dual-chamber pacing and the addition ofdiphcnylhydantoin 
Revtow studies. A recenf report by Moss et al. (16) 
therapy. One striking finding was the relation of bigeminy to 
polymorphous ventricular tachycardia. Aithough the mean 
descri’led the beneficial effects of comtination therapy for 30 
heart rate was more rapid during bigeminy than that re- 
corded during dual-chamber pacing, polymorphous ventric- 
ular txhycardia disappeared after the disappearance of 
prematwe venrricular complexes. This finding suggests that 
the she?-long sequences induced by premature ventricular 
:omple ves may trigger polymorphous ventricular tachycar- 
dia. On: possible mechanism may involve the induction cf 
afterdepolarization as a result of either increased intracellu- 
lar talcum concentration after the premature complex (II) 
or direct mechanical stress and stretch (12) produced by the 
extrasyirolic beat. The findings in these two patientx suggest 
that factors apart from prolonged pauses or enhanced bcta- 
aborted sudden dea:h. occurred despite continuation of patier ts with the long QT syndrome enrolled in a v&ntary 
beta-blocker therapy in IGZW of patients who underwent registry. They described recurrent symptoms in 9 of 30 
sympathectomy. patients. The diierence in recu*ence rate between studies 
Results of mmbIation therapy. In 1987, we (2) intro- may be due to differences in the paced rate used. In our 
duced the concept of combination beta-blocker therapy and study, the minimal paced rate needed to normalize the QT 
cardiac pacing for all patients with the long QT syndrome. interval was used. In the study of Moss et al., the paced rate 
The rationale for this approach was prevention of either was known il? Wpatients (69 2 Sbeatslmi” in 6patie”tr with 
pauses or inweased &en&c tone that might trigger epi- cardiac events and 75 i It beat&i” in 13 without events) 
sodes of polymorphous ventricular tachycardia. In this and was associated with normalization of the QT interval in 
studv. we describe a relatively long-term follow-up in a IO patients. In addition, the causes of symptomatic recur- 
sizable group of high risk patients. Itis difficult to compare 
our oatients with those in orior rewrts: however. their 
ch&cteristics appeared to Iii those df a relatively high risk 
group. For example, 18 (86%) of the 21 patients had syn- 
cope, S (38%) had been resuscitated from an episode of 
sudden cardiac death. II 02%) had a family history of 
sudden cardiac death or recurrent syncope. aid 9 had not 
responded to a trial of beta-blockers with (5 patients) or 
without left cervicothoracic sympathectomy. 
Lompliwdlons. Despite the apparent high risk, none of 
the patients who adhered to the recommended combination 
therapy died suddenly. The only sudden death occurred in a 
patient who discontinued the use of beta-blockers. Of major 
concern were two patients W%) who experienced recurrent 
rrowpr &iie rect?ung combination therapy. One (Patient 
2) had an AA1 pacemaker, and we cannot exclude the 
rences were not defined and the issue of possible pacemaker 
malfunction was not addressed. It is conceivable that the 
higher incidence of adverse effects noted in the study by 
Moss et al. was conceivably due either to failure to “ormal- 
ize the QT interval with pacing or to pacemaker malfunction 
in some patients, or to both. Similar considerations apply to 
.a case repon by Case and Gillette (17) of a child who did not 
respond to pacemaker therapy. 
Pacemaker probIems. The inadequacy of isolated atrial 
pacing was appreciated relaihely e&y ia our experience. In 
five patienrs, spontaneous or induced episodes of AV block 
were recorded and the block wzs documented to be infra- 
Hisian in four, including two siblings (Patients 3 and 21). 
Previous studies from our laboratory and others (6.17-u)) 
have documented the functional nature of this block, which 
may be initiated, for example, by a compensatory pause 
after B premature ventricular depolarization resulting in 
increased retractoriness of the His-Purkinje system. Once 
black occurs, it tends to he perpetuated by the pause 
omduced by AV block 0). In addition, we noted soontane- 
bus episodes of Mobitz type 1 AV block in one patient. The 
incidence of AV block would be expected to bc increased in 
patients treated with large doses of beta-blockers. In view of 
these findings, our preference is to use dual-chamber pace- 
makers in adults with the long QT syndrome. 
The unique requirements for the maintenance ofa specific 
late for QT normalization in patients with prolonged refrac- 
tory periods produce interesting pacemakkr problems. For 
example, maintenance of a critical rate and provision for 
adequate AV delay to allow intrinsic AV conduction resulted 
in a pacemaker syndrome in Patient 9. In this patient, 
retrograde atrial depolarization fell in the atria.1 refractory 
period end the atrium was refractory to the subsequent 
paced nrihl ever.: (4;. 
Other significant problems may rela:e to sensing of T and 
U waves, which may be abnormal in these patients (2). TU 
wave and pacemaker stimulus afterpotential oversensing 
have to be avoided to prevent pauses that may potentially 
trigger episodes of polymorphous ventricular tachycardia 
and may require programming of relatively long refractory 
periods. In one patient, sinus complexes during sinus tachy- 
cardia were not sensed because of a long programmed 
refractory period, and bursts of nonsor!ained vntric~dar 
tachycardia resulted when pacemaker spikes fell on the T 
wave (Fig. 3). The problem &MI? ‘x res&ed in this patient 
by shortening the refractory pclmd. Oversensing proved to 
be a problem in one patient (Patient 16) in whom intra- 
cardiac telemetry showed a very large potential after the T 
wave, which was sensed and led to pauses (Fig. 2). The 
cawe of this unusual potential is not clear. It could represent 
“noise” due to lead fracture or insulation break. However, 
there was no other indication of a lead problem. Some 
screw-in leads may muse artifactual potentials probably due 
to intermittent contact between the screw and the ring 
cathode (21). In this patient, deep breathing and rapid heart 
rates neither changed nor accentuated the potentials. An- 
other possible explanation is that they represent local abnor- 
mal afterdepolarizations. However, their huge amplitude. 
inconstant relation to the previous QRS complex and lack of 
constant relasion to heart rate do not favor this expiwation. 
Whatever the mechanism, oversensing should be corrected 
to avoid pause-dependent arrhythmia. This case underlines 
the importance of lead telemetry for identifying the mecha- 
nism of oversensing. 
Fmdiigs in family members. Another interesting obser- 
vation emerged from our study. An asymptomatic family 
member with serial ECGs showing normal QT and QTc 
intervals had an episode of sudden cardiac arrest, suggesting 
that apparently unaffected siblings are still at risk. Cardiac 
symptoms in unaKected members of a family with the long 
QT syndrome have been previously reported (6.22). but we 
are unaware of prior repons of aborted sudden cardiac death 
in asymptomatic siblings with a nomtal QT interval. 
Limitations. Some patients had a relatively short 
follow-up interval. which poses difficulties in assessing the 
impact of combination therapy. Two patients (Patients 9 and 
10) had only one episode of syncope before they were given 
combination therapy, whereas one patient (Patient 21) was 
asymptomatic and had a short (I-month) follow-up period. 
However. Patieni IO had documented polymorphic ventric- 
ular tachycsrdia before and after left cervicothoracic sym- 
pathectomy and remains asymptomatic after combination 
therapy. 
Although all of our patients received combination ther- 
apy, the possibility that either treatment alone might have 
sufficed cannot be excluded. The reappearance of symptoms 
on d:;continuation of either pacing (Patients 3 and 19) or 
beta-blockers (Patient 20) supports the hypothesis that both 
components are important but does not prove it. For exam- 
ple, Patient 20, who had an AA1 pacemaker, may not have 
responded to treatment because of intermittent AV block 
that triggered polymorphous ventricular tachycardia. 
Conclusions. Over a follow-up interval of 55 months, 
none of the patients who had long-term combination therapy 
had sudden cardiac death. This therapy is not without risk 
because two ofthese patients (10%) did &perience recurrent 
syncope and one had documented polymorphous ventricular 
tachycardia. Three other patients experienced recurrence of 
symptoms related to paicnakcr malfxtction. These results 
provide long-term data on combination therapy and appear 
to compare favorably with results obtained with beta block- 
ers used alone or in addition to sympathectomy. Moreover, 
in patients with the long QT syndrome who are deemed 
candidates for an internal defibrillator, the combination of 
beta-blockers and long-term pacing is recommended to de- 
crease the number of defibrillator discharges. 
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